Loading...
Research progress in immune checkpoint inhibitors for lung cancer in China
Immune checkpoint inhibitors (ICIs) have come to play an increasingly prominent role in the treatment of lung cancer, and some are recommended as a first-line treatment for late-stage non-small-cell lung cancer, either as a monotherapy or in combination with chemotherapy. Accordingly, the indication...
Na minha lista:
| Udgivet i: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8295948/ https://ncbi.nlm.nih.gov/pubmed/34349843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211029826 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|